🔗 Share this article

This year's prestigious award in medical science was granted for transformative discoveries that clarify how the body's defense network attacks dangerous pathogens while protecting the healthy tissues.

A trio of renowned scientists—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

The research identified unique "sentinels" within the immune system that remove malfunctioning immune cells that could harming the body.

These findings are now paving the way for new treatments for immune disorders and malignancies.

The laureates will share a prize fund valued at 11m Swedish kronor.

Crucial Discoveries

"Their research has been decisive for understanding how the immune system functions and why we don't all suffer from severe self-attack conditions," stated the head of the Nobel Committee.

This team's studies explain a core question: In what way does the immune system protect us from countless infections while keeping our own tissues intact?

Our body's protection system uses immune cells that scan for indicators of infection, including viruses and germs it has never encountered.

Such defenders employ sensors—called recognition units—that are produced randomly in a vast number of variations.

This provides the defense network the capacity to combat a broad range of threats, but the randomness of the process inevitably produces white blood cells that can attack the host.

Security Guards of the Body

Researchers earlier knew that a portion of these problematic defense cells were eliminated in the immune organ—the site where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "peacekeepers"—which travel through the system to neutralize other immune cells that assault the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The discoveries have laid the foundation for a novel area of investigation and spurred the development of new therapies, for instance for cancer and autoimmune diseases."

In malignancies, T-regs prevent the system from attacking the growth, so research are focused on lowering their numbers.

For self-attack disorders, trials are testing increasing regulatory T-cells so the body is no longer under attack. A comparable method could also be useful in minimizing the risks of transplanted organ rejection.

Pioneering Experiments

Prof Sakaguchi, from a Japanese institution, conducted tests on rodents that had their thymus extracted, leading to self-attack conditions.

He demonstrated that introducing defense cells from other mice could prevent the illness—suggesting there was a mechanism for preventing defenders from attacking the body.

Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in rodents and people that led to the identification of a genetic factor vital for the way T-regs operate.

"Their pioneering work has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a leading biological science specialist.

"This research is a striking illustration of how fundamental physiological research can have far-reaching implications for human health."